Glenn Frank Short, Chief Scientific Officer at ATAI Life Sciences N.V. (ATAI), sold 13,161 shares at $1.35 ($18K) on 2025-03-21, disclosed to the SEC on 2025-03-24.
Open-market sale of $18k ATAI by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.